Treatment of recalcitrant atopic dermatitis with omalizumab.

Lane, Joshua E; Cheyney, Jason M; Lane, Tanda N; Kent, David E; Cohen, David J

Lane, Joshua E; Cheyney, Jason M; Lane, Tanda N; Kent, David E; Cohen, David J.

Affiliation

Lane JE; Division of Dermatology, Department of Internal Medicine, Mercer University School of Medicine, Macon, Georgia 31217, USA. joshua.lane@lycos.com

J Am Acad Dermatol ; 54(1): 68-72, 2006 Jan.

Article in En | MEDLINE | ID: mdl-16384758

Subject(s)

Antibodies, Monoclonal/therapeutic use; Dermatitis, Atopic/drug therapy; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal/administration & dosage; Antibodies, Monoclonal, Humanized; Child; Dermatitis, Atopic/pathology; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Humans; Injections, Subcutaneous; Omalizumab; Treatment Outcome

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Dermatitis, Atopic / Antibodies, Monoclonal Limits: Child / Female / Humans Language: En Year: 2006 Type: Article

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Dermatitis, Atopic / Antibodies, Monoclonal Limits: Child / Female / Humans Language: En Year: 2006 Type: Article